|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 17
Zeitschriftenartikel
D'Erasmo, Laura; Giammanco, Antonina; Suppressa, Patrizia; Pavanello, Chiara; Iannuzzo, Gabriella; Di Costanzo, Alessia; Tramontano, Daniele; Minicocci, Ilenia; Bini, Simone; Vogt, Anja; Stewards, Kim; Roeters Van Lennep, Jeanine; Bertolini, Stefano und Arca, Marcello
(2022):
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study.
In: Frontiers in Genetics, Bd. 13, 937750
Schettler, Volker J. J.; Peter, Christian; Zimmermann, Thomas; Julius, Ulrich; Roeseler, Eberhard; Schlieper, Georg; Heigl, Franz; Gruetzmacher, Peter; Loehlein, Iris; Klingel, Reinhard; Hohenstein, Bernd; Ramlow, Wolfgang und Vogt, Anja
(2022):
The German Lipoprotein Apheresis Registry-Summary of the ninth annual report.
In: Therapeutic Apheresis and Dialysis, Bd. 26, Nr. SUPPL 1: S. 81-88
Ray, Kausik K.; Dhalwani, Nafeesa; Sibartie, Mahendra; Bridges, Ian; Ebenbichler, Christoph; Perrone-Filardi, Pasquale; Villa, Guillermo; Vogt, Anja und Bruckert, Eric
(2022):
Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study.
In: European Heart Journal - Quality of Care and Clinical Outcomes, Bd. 8, Nr. 4: S. 447-460
Hollstein, Tim; Vogt, Anja; Grenkowitz, Thomas; Stojakovic, Tatjana; Maerz, Winfried; Laufs, Ulrich; Boeluekbasi, Bediha; Steinhagen-Thiessen, Elisabeth; Scharnagl, Hubert und Kassner, Ursula
(2019):
Treatment with PCSK9 inhibitors reduces atherogenic VLDL remnants in a real-world study.
In: Vascular Pharmacology, Bd. 116: S. 8-15
Klingel, Reinhard; Heigl, Franz; Schettler, Volker; Roeseler, Eberhard; Gruetzmacher, Peter; Hohenstein, Bernd; Vogt, Anja; Fassbender, Cordula; Heibges, Andreas und Julius, Ulrich
(2019):
Lipoprotein(a) - Marker for cardiovascular risk and target for lipoprotein apheresis.
In: Atherosclerosis Supplements, Bd. 40: S. 17-22
Waldmann, Elisa; Vogt, Anja; Crispin, Alexander; Altenhofer, Julia; Riks, Ina und Parhofer, Klaus Georg
(2018):
Reply to: “Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis: Corrections of the report on the randomized MICA-study”.
In: Atherosclerosis, Bd. 275: S. 459-460
D'Erasmo, Laura; Minicocci, Ilenia; Nicolucci, Antonio; Pintus, Paolo; Van Lennep, Janine E. Roeters; Masana, Luis; Mata, Pedro; Maria Sanchez-Hernandez, Rosa; Prieto-Matos, Pablo; Real, Jose T.; Ascaso, Juan F.; Esteve Lafuente, Eduardo; Pocovi, Miguel; Fuentes, Francisco J.; Muntoni, Sandro; Bertolini, Stefano; Sirtori, Cesare; Calabresi, Laura; Pavanello, Chiara; Averna, Maurizio; Cefalu, Angelo Baldassare; Noto, Davide; Pacifico, Adolfo Arturo; Pes, Giovanni Mario; Harada-Shiba, Mariko; Manzato, Enzo; Zambon, Sabina; Zambon, Alberto; Vogt, Anja; Scardapane, Marco; Sjouke, Barbara; Fellin, Renato und Arca, Marcello
(2018):
Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular Outcomes.
In: Journal of the American College of Cardiology, Bd. 71, Nr. 3: S. 279-288
Schmidt, Nina; Dressel, Alexander; Grammer, Tanja B.; Gouni-Berthold, Ioanna; Julius, Ulrich; Kassner, Ursula; Klose, Gerald; König, Christel; König, Wolfgang; Otte, Britta; Parhofer, Klaus G.; Reinhard, Wibke; Schatz, Ulrike; Schunkert, Heribert; Steinhagen-Thiessen, Elisabeth; Vogt, Anja; Laufs, Ulrich und März, Winfried
(2018):
Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry.
In: Atherosclerosis, Bd. 277: S. 314-322
Waldmann, Elisa; Vogt, Anja; Crispin, Alexander; Altenhofer, Julia; Riks, Ina und Parhofer, Klaus G.
(2018):
Corrigendum to: “Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study)” [Atherosclerosis 259 (2017 Apr) 20–25].
In: Atherosclerosis, Bd. 275: S. 461-462
Waldmann, Elisa; Vogt, Anja; Crispin, Alexander; Altenhofer, Julia; Riks, Ina und Parhofer, Klaus G.
(2017):
Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study).
In: Atherosclerosis, Bd. 259: S. 20-25
Paulin, Nicole; Döring, Yvonne; Kooijman, Sander; Blanchet, Xavier; Viola, Joana R.; Jong, Renske de; Mandl, Manuela; Hendrikse, Jeffrey; Schiener, Maximilian; Hundelshausen, Philipp von; Vogt, Anja; Weber, Christian; Bdeir, Khalil; Hofmann, Susanna M.; Rensen, Patrick C. N.; Drechsler, Maik und Soehnlein, Oliver
(2017):
Human Neutrophil Peptide 1 Limits Hypercholesterolemia-induced Atherosclerosis by Increasing Hepatic LDL Clearance.
In: Ebiomedicine, Bd. 16: S. 204-211
Kahnert, Kathrin; Lucke, Tanja; Huber, Rudolf M.; Behr, Jürgen; Biertz, Frank; Vogt, Anja; Watz, Henrik; Alter, Peter; Fähndrich, Sebastian; Bals, Robert; Holle, Rolf; Karrasch, Stefan; Sohler, Sandra; Wacker, Margarethe; Ficker, Joachim H.; Parhofer, Klaus G.; Vogelmeier, Claus und Jörres, Rudolf A.
(2017):
Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort.
In: PLOS One 12(5), e0177501 [PDF, 4MB]
In: PLOS One 12(5), e0177501 [PDF, 4MB]
Vogt, Anja
(2017):
Lipoprotein(a)-apheresis in the light of new drug developments.
In: Atherosclerosis Supplements, Bd. 30: S. 38-43
Moriarty, Patrick M.; Parhofer, Klaus G.; Babirak, Stephan P.; Cornier, Marc-Andre; Duell, P. Barton; Hohenstein, Bernd; Leebmann, Josef; Ramlow, Wolfgang; Schettler, Volker; Simha, Vinaya; Steinhagen-Thiessen, Elisabeth; Thompson, Paul D.; Vogt, Anja; Stritzky, Berndt von; Du, Yunling und Manvelian, Garen
(2016):
Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial.
In: European Heart Journal, Bd. 37, Nr. 48: S. 3588-3595
Moriarty, Patrick M.; Parhofer, Klaus G.; Babirak, Stephan P.; deGoma, Emil; Duell, P. Barton; Hohenstein, Bernd; Ramlow, Wolfgang; Simha, Vinaya; Steinhagen-Thiessen, Elisabeth; Thompson, Paul D.; Vogt, Anja; Stritzky, Berndt von; Du, Yunling und Manvelian, Garen
(2016):
Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial.
In: Journal of Clinical Lipidology, Bd. 10, Nr. 3: S. 627-634
Rodrigues, Rute; Artieda, Marta; Tejedor, Diego; Martínez, Antonio; Konstantinova, Pavlina; Petry, Harald; Meyer, Christian; Corzo, Deyanira; Sundgreen, Claus; Klor, Hans U.; Gouni-Berthold, Ioanna; Westphal, Sabine; Steinhagen-Thiessen, Elisabeth; Julius, Ulrich; Winkler, Karl; Stroes, Erik; Vogt, Anja; Hardt, Phillip; Prophet, Heinrich; Otte, Britta; Nordestgaard, Borge G.; Deeb, Samir S. und Brunzell, John D.
(2016):
Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency.
In: Journal of Clinical Lipidology, Bd. 10, Nr. 2: S. 394-409
Rosada, Adrian; Kassner, Ursula; Banisch, Dagmar; Bender, Andrew; Steinhagen-Thiessen, Elisabeth und Vogt, Anja
(2016):
Quality of life in patients treated with lipoprotein apheresis.
In: Journal of Clinical Lipidology, Bd. 10, Nr. 2: S. 323-329